Home › Type 1 Diabetes › Minnesota › Rochester
Type 1 Diabetes clinical trials in Rochester, MN
4 studies for Type 1 Diabetes are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
RecruitingPhase 3
- Mayo Clinic in Rochester - Minnesota- Site Number : 8400019, Rochester
Kidney Precision Medicine Project
RecruitingObservational study
- Mayo Clinic, Rochester, Rochester
Registry for Stage 2 Type 1 Diabetes
RecruitingObservational study
- Mayo Clinic- Site Number : 8400010, Rochester
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
About Type 1 Diabetes
If the pancreas doesn't make needed insulin, causing blood sugar levels to be too high you have type 1 or juvenile diabetes. Learn the signs.
More about Type 1 Diabetes on MedlinePlus
Type 1 Diabetes trials in other cities
- Aurora, CO23 studies
- Boston, MA21 studies
- Seattle, WA18 studies
- Chicago, IL16 studies
- New York City, NY15 studies
- New Haven, CT15 studies
- Indianapolis, IN14 studies
- San Francisco, CA14 studies
- Miami, FL13 studies
- Gainesville, FL12 studies
- Philadelphia, PA11 studies
- Atlanta, GA11 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Multiple Myeloma24 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Pancreatic Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.